137 related articles for article (PubMed ID: 21885165)
1. Anti-cancer activity of a novel palladium(II) complex on human breast cancer cells in vitro and in vivo.
Ulukaya E; Ari F; Dimas K; Ikitimur EI; Guney E; Yilmaz VT
Eur J Med Chem; 2011 Oct; 46(10):4957-63. PubMed ID: 21885165
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-inducing effect of a palladium(II) saccharinate complex of terpyridine on human breast cancer cells in vitro and in vivo.
Ari F; Cevatemre B; Armutak EI; Aztopal N; Yilmaz VT; Ulukaya E
Bioorg Med Chem; 2014 Sep; 22(17):4948-54. PubMed ID: 25047941
[TBL] [Abstract][Full Text] [Related]
3. Palladium(II) saccharinate complexes with bis(2-pyridylmethyl)amine induce cell death by apoptosis in human breast cancer cells in vitro.
Ari F; Ulukaya E; Sarimahmut M; Yilmaz VT
Bioorg Med Chem; 2013 Jun; 21(11):3016-21. PubMed ID: 23601820
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect of a novel palladium-saccharinate complex of terpyridine by inducing apoptosis on Ehrlich ascites carcinoma (EAC) in Balb-C mice.
Ikitimur-Armutak EI; Sonmez K; Akgun-Dar K; Sennazli G; Kapucu A; Yigit F; Yilmaz VT; Ulukaya E
Anticancer Res; 2015 Mar; 35(3):1491-7. PubMed ID: 25750302
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and proteomic analysis of a potential anticancer agent: Palladium(II) Saccharinate complex of terpyridine acting through double strand break formation.
Adiguzel Z; Baykal AT; Kacar O; Yilmaz VT; Ulukaya E; Acilan C
J Proteome Res; 2014 Nov; 13(11):5240-9. PubMed ID: 25210790
[TBL] [Abstract][Full Text] [Related]
6. Promising anti-growth effects of palladium(II) saccharinate complex of terpyridine by inducing apoptosis on transformed fibroblasts in vitro.
Coskun MD; Ari F; Oral AY; Sarimahmut M; Kutlu HM; Yilmaz VT; Ulukaya E
Bioorg Med Chem; 2013 Aug; 21(15):4698-705. PubMed ID: 23751940
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the molecular mechanisms of a palladium(II) saccharinate complex with terpyridine as an anticancer agent.
Kacar O; Adiguzel Z; Yilmaz VT; Cetin Y; Cevatemre B; Arda N; Baykal AT; Ulukaya E; Acilan C
Anticancer Drugs; 2014 Jan; 25(1):17-29. PubMed ID: 24045367
[TBL] [Abstract][Full Text] [Related]
8. Apoptosis-inducing Effect of a Palladium(II) Complex-[PdCl(terpy)](sac).2H2O] on Ehrlich Ascites Carcinoma (EAC) in Mice.
Ikitimur-Armutak EI; Ulukaya E; Gurel-Gurevin E; Yaylim I; Isbilen-Basok B; Sennazli G; Yuzbasioglu-Ozturk G; Sonmez K; Celik F; Kucukhuseyin O; Korkmaz G; Yilmaz VT; Zeybek SU
In Vivo; 2016; 30(4):457-64. PubMed ID: 27381609
[TBL] [Abstract][Full Text] [Related]
9. Biologic activity of a dinuclear Pd(II)-spermine complex toward human breast cancer.
Fiuza SM; Holy J; Batista de Carvalho LA; Marques MP
Chem Biol Drug Des; 2011 Jun; 77(6):477-88. PubMed ID: 21371266
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization and cell death-inducing effect of novel palladium(II) and platinum(II) saccharinate complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine on cancer cells in vitro.
Ari F; Aztopal N; Icsel C; Yilmaz VT; Guney E; Buyukgungor O; Ulukaya E
Bioorg Med Chem; 2013 Nov; 21(21):6427-34. PubMed ID: 24054490
[TBL] [Abstract][Full Text] [Related]
11. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
Park SK; Sanders BG; Kline K
Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of novel palladium-based compounds on leukemia cell lines.
Antunovic M; Kriznik B; Ulukaya E; Yilmaz VT; Mihalic KC; Madunic J; Marijanovic I
Anticancer Drugs; 2015 Feb; 26(2):180-6. PubMed ID: 25280061
[TBL] [Abstract][Full Text] [Related]
13. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines.
Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR
Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732
[TBL] [Abstract][Full Text] [Related]
14. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.
Shi YK; Li ZH; Han XQ; Yi JH; Wang ZH; Hou JL; Feng CR; Fang QH; Wang HH; Zhang PF; Wang FS; Shen J; Wang P
Cancer Chemother Pharmacol; 2010 Nov; 66(6):1131-40. PubMed ID: 20838997
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, interaction with DNA, and cytotoxic effect in vitro of new mono- and dinuclear Pd(II) and Pt(II) complexes with benzo[d]thiazol-2-amine as the primary ligand.
Gao E; Liu L; Zhu M; Huang Y; Guan F; Gao X; Zhang M; Wang L; Zhang W; Sun Y
Inorg Chem; 2011 Jun; 50(11):4732-41. PubMed ID: 21520903
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of novel substituted 5-hydroxycoumarin and pyranocoumarin derivatives exhibiting significant antiproliferative activity against breast cancer cell lines.
Mao WW; Wang TT; Zeng HP; Wang ZY; Chen JP; Shen JG
Bioorg Med Chem Lett; 2009 Aug; 19(16):4570-3. PubMed ID: 19616431
[TBL] [Abstract][Full Text] [Related]
18. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
19. Anti-oxidant, in vitro, in vivo anti-inflammatory activity and antiproliferative activity of mefenamic acid and its metal complexes with manganese(II), cobalt(II), nickel(II), copper(II) and zinc(II).
Kovala-Demertzi D; Hadjipavlou-Litina D; Staninska M; Primikiri A; Kotoglou C; Demertzis MA
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):742-52. PubMed ID: 18720191
[TBL] [Abstract][Full Text] [Related]
20. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL
Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
